Logo image of ALHUN.PA

HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

EPA:ALHUN - Euronext Paris - Matif - FR0014007LQ2 - Common Stock - Currency: EUR

8.8  +0.06 (+0.69%)

Fundamental Rating

4

Overall ALHUN gets a fundamental rating of 4 out of 10. We evaluated ALHUN against 51 industry peers in the Specialty Retail industry. There are concerns on the financial health of ALHUN while its profitability can be described as average. ALHUN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALHUN was profitable.
ALHUN had a negative operating cash flow in the past year.
In the past 5 years ALHUN has always been profitable.
Of the past 5 years ALHUN 4 years had a positive operating cash flow.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

ALHUN's Return On Assets of 1.91% is fine compared to the rest of the industry. ALHUN outperforms 60.78% of its industry peers.
ALHUN has a Return On Equity of 6.43%. This is in the better half of the industry: ALHUN outperforms 62.75% of its industry peers.
The Return On Invested Capital of ALHUN (5.48%) is better than 64.71% of its industry peers.
ALHUN had an Average Return On Invested Capital over the past 3 years of 9.61%. This is in line with the industry average of 8.16%.
The 3 year average ROIC (9.61%) for ALHUN is well above the current ROIC(5.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROIC 5.48%
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of ALHUN (1.41%) is better than 62.75% of its industry peers.
ALHUN's Profit Margin has declined in the last couple of years.
ALHUN has a Operating Margin (2.48%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALHUN has declined.
ALHUN has a worse Gross Margin (19.89%) than 76.47% of its industry peers.
ALHUN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALHUN is still creating some value.
Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
The number of shares outstanding for ALHUN has been increased compared to 5 years ago.
ALHUN has a worse debt/assets ratio than last year.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALHUN has an Altman-Z score of 2.35. This is not the best score and indicates that ALHUN is in the grey zone with still only limited risk for bankruptcy at the moment.
ALHUN has a better Altman-Z score (2.35) than 60.78% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that ALHUN is somewhat dependend on debt financing.
The Debt to Equity ratio of ALHUN (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACC0.86
WACC6.38%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

ALHUN has a Current Ratio of 1.66. This is a normal value and indicates that ALHUN is financially healthy and should not expect problems in meeting its short term obligations.
ALHUN has a Current ratio of 1.66. This is in the better half of the industry: ALHUN outperforms 76.47% of its industry peers.
ALHUN has a Quick Ratio of 1.66. This is a bad value and indicates that ALHUN is not financially healthy enough and could expect problems in meeting its short term obligations.
ALHUN has a Quick ratio (0.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 0.46
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

ALHUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.70%.
ALHUN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
ALHUN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.96%.
Measured over the past years, ALHUN shows a very strong growth in Revenue. The Revenue has been growing by 26.45% on average per year.
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%

3.2 Future

The Earnings Per Share is expected to grow by 25.58% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHUN will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5Y25.58%
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5Y4.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.33, ALHUN is valued on the expensive side.
Based on the Price/Earnings ratio, ALHUN is valued a bit cheaper than 78.43% of the companies in the same industry.
ALHUN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.68 indicates a reasonable valuation of ALHUN.
82.35% of the companies in the same industry are more expensive than ALHUN, based on the Price/Forward Earnings ratio.
ALHUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.33
Fwd PE 10.68
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHUN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.78
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ALHUN's earnings are expected to grow with 18.72% in the coming years.
PEG (NY)2.07
PEG (5Y)N/A
EPS Next 2Y20.66%
EPS Next 3Y18.72%

0

5. Dividend

5.1 Amount

No dividends for ALHUN!.
Industry RankSector Rank
Dividend Yield N/A

HUNYVERS SACA

EPA:ALHUN (7/28/2025, 7:00:00 PM)

8.8

+0.06 (+0.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap34.06M
Analysts88
Price Target10.56 (20%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.16%
PT rev (3m)-26.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.33
Fwd PE 10.68
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 2.14
EV/EBITDA 12.78
EPS(TTM)0.48
EY5.45%
EPS(NY)0.82
Fwd EY9.36%
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS33.68
BVpS7.38
TBVpS4.12
PEG (NY)2.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 6.43%
ROCE 6.65%
ROIC 5.48%
ROICexc 6.59%
ROICexgc 9.48%
OM 2.48%
PM (TTM) 1.41%
GM 19.89%
FCFM N/A
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ROICexc(3y)11.28%
ROICexc(5y)11.76%
ROICexgc(3y)15.77%
ROICexgc(5y)16.95%
ROCE(3y)12.12%
ROCE(5y)10.83%
ROICexcg growth 3Y-40.67%
ROICexcg growth 5YN/A
ROICexc growth 3Y-38.4%
ROICexc growth 5YN/A
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 5.16
Cap/Depr 114.18%
Cap/Sales 0.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 0.46
Altman-Z 2.35
F-Score4
WACC6.38%
ROIC/WACC0.86
Cap/Depr(3y)138.87%
Cap/Depr(5y)108.48%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.7%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%-1.2%
EPS Next Y8.84%
EPS Next 2Y20.66%
EPS Next 3Y18.72%
EPS Next 5Y25.58%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%17.55%
Revenue Next Year12.96%
Revenue Next 2Y8.73%
Revenue Next 3Y7.16%
Revenue Next 5Y4.7%
EBIT growth 1Y-40.5%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year42.55%
EBIT Next 3Y22.31%
EBIT Next 5Y24.53%
FCF growth 1Y-2895.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.17%
OCF growth 3YN/A
OCF growth 5YN/A